ArticleFrontiers in immunology2022

LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.

Leticia Corrales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.